The Brain & Behavior Research Foundation celebrated 25 years of Empowering Research for Productive Lives and honored eight extraordinary scientists at its Annual National Awards Dinner in New York City on October 26.

Eduard Vieta Ph.D., was one of two winners of the Colvin Prize for Outstanding Achievement in Mood Disorders Research this year. Dr. Vieta is Professor and Head of the Department of Psychiatry and Director of the Bipolar Disorders Program of the Hospital Clinic at the University of Barcelona. He is also the Director of the Bipolar Research Program of the Spanish Research Network on Mental Diseases. Dr. Vieta has made remarkable contributions to the understanding and treatment of bipolar disorder that have helped improve the lives of millions of individuals with bipolar disorder around the globe. His studies range from those that have demonstrated the efficacy of the most widely used atypical antipsychotic—quetiapine (Seroquel®)—in monotherapy and combination therapy in the long term prevention of both manic and depressive episodes to one that showed the effectiveness of gabapentin (Neurontin®) as augmentation therapy in long term prophylaxis. He and his group have also pioneered in demonstrating the acute and lasting effectiveness of psycho-education and related psychotherapeutic approaches in the treatment of bipolar disorder.

Dr. Vieta was selected through a peer-review process of the Brain & Behavior Research Foundation Scientific Council, a volunteer group of 138 pre-eminent mental health researchers. These annual prizes are amongst the most prestigious recognitions possible in psychiatric research.

Learn more about Dr. Vieta in this Press Release